Pathos
Phillip Comella, Ph.D. is a Senior Computational Biologist at Pathos, where Phillip played a key role in constructing causal AI models for network characterizations in cancer research. Phillip has also worked as a Postdoctoral Fellow at Icahn School of Medicine at Mount Sinai and a Scientist II at GeneDx. Phillip has a diverse educational background in Biomedical Sciences, Genetics, Biology, Vaccinology, Chemistry, and Classical Studies from various institutions, including Icahn School of Medicine at Mount Sinai and Concordia College. Throughout their career, Phillip has demonstrated strong leadership skills in research, development, and academic roles.
This person is not in any offices
Pathos
1 followers
Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy. It also helps drug developers to explore novel concepts, and advance breakthroughtherapies. The company's OS platform is capable of managing the entire end-to-end process of designing and developing novel therapeutics.